Magnetic labeling of non-phagocytic adherent cells with iron oxide nanoparticles: A comprehensive study

Contrast Media and Molecular Imaging

Volumn 3, Issue 6, 2008, Pages 223-232

  Boutry, Sébastien ^a   Brunin, Stéphanie ^a   Mahieu, Isabelle ^a   Laurent, Sophie ^a   Vander Elst, Luce ^a   Muller, Robert N ^a  

^a UNIVERSITY OF MONS   (Belgium)

Author keywords

Cells; Iron oxide; Magnetic labeling; Nanoparticles

Indexed keywords

DEXTRAN; FERUCARBOTRAN; IRON OXIDE; NANOPARTICLE; SMALL SUPERPARAMAGNETIC IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERRIC ION; FERRIC OXIDE; IRON; OXIDE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; CELL LABELING; CELL MEMBRANE PERMEABILITY; CELL TRANSPORT; CELL VIABILITY; CHEMICAL ANALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOCHEMISTRY; FIBROBLAST; MATERIAL COATING; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHAGOCYTE; PRIORITY JOURNAL; ANALYTICAL EQUIPMENT; ANIMAL; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; EVALUATION; METABOLISM; METHODOLOGY; RAT; STAINING; STANDARD; STROMA CELL;

ANIMALS; BONE MARROW CELLS; CELL SURVIVAL; CELLS, CULTURED; CONTRAST MEDIA; DEXTRANS; FERRIC COMPOUNDS; FIBROBLASTS; IRON; MAGNETIC RESONANCE IMAGING; MICE; NANOPARTICLES; OXIDES; RATS; REAGENT KITS, DIAGNOSTIC; STAINING AND LABELING; STROMAL CELLS;

EID: 58749096917     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.256     Document Type: Article

References (46)

1. Modo M, Hoehn M, Bulte JW. Cellular MR imaging. Mol. Imag. 2005; 4: 143-164.
2. Artemov D. Molecular magnetic resonance imaging with targeted contrast agents. J. Cell Biochem. 2003; 90: 518-524.
3. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17: 484-499.
4. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur. Radiol. 2001; 11: 2319-2331.
5. Mornet S, Vasseur S, Grasset F, Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 2004; 14: 2161-2175.
6. Reimer P, Tombach B. Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur. Radiol. 1998; 8: 1198-1204.
7. Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H. Tissue-specific MR contrast agents. Eur. J. Radiol. 2003; 46: 33-44.
8. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. MRI detection of single particles for cellular imaging. Proc. Natl Acad. Sci. USA 2004; 101: 10901-10906.
9. Shapiro EM, Sharer K, Skrtic S, Koretsky AP. In vivo detection of single cells by MRI. Magn. Reson. Med. 2006; 55: 242-249.
10. Shapiro EM, Skrtic S, Koretsky AP. Sizing it up: cellular MRI using micron-sized iron oxide particles. Magn. Reson. Med. 2005; 53: 329-338.
11. Wu YL, Ye Q, Foley LM, Hitchens TK, Sato K, Williams JB, Ho C. In situ labeling of immune cells with iron oxide particles: an approach to detect organ rejection by cellular MRI. Proc. Natl Acad. Sci. USA 2006; 113: 1852-1857.
12. Dousset V, Doche B, Petry KG, Brochet B, Delalande C, Caille JM. Correlation between clinical status and macrophage activity imaging in the central nervous system of rats. Acad. Radiol. 2002; 9(suppl. 1): S156-S159.
13. Sykova E, Jendelova P. Magnetic resonance tracking of implanted adult and embryonic stem cells in injured brain and spinal cord. Ann. NY Acad. Sci. 2005; 1049: 146-160.
14. Schoepf U, Mercos EM, Melder RJ, Jain RK, Weissleder R. Intracellular magnetic labeling of lymphocytes for in vivo trafficking studies. Biotechniques 1998; 24: 642-646, 648-651.
15. Jendelova P, Herynek V, DeCroos J, Glogarova K, Andersson B, Hajek M, Sykova E. Imaging the fate of implanted bone marrow stromal cells labeled with superparamagnetic nanoparticles. Magn. Reson. Med. 2003; 50: 767-776.
16. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, Bryant LH, Bulte JW. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003; 228: 480-487.
17. Bulte JW. Magnetic nanoparticles as markers for cellular MR imaging. J. Magn. Magn. Mater. 2005; 289: 423-427.
18. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004; 104: 1217-1223.
19. Arbab AS, Yocum GT, Wilson LB, Parwana A, Jordan EK, Kalish H, Frank JA. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol. Imag. 2004; 3: 24-32.
20. Hoehn M, Kustermann E, Blunk J, Wiedermann D, Trapp T,Wecker S, Focking M, Arnold H, Hescheler J, Fleischmann BK, Schwindt W, Buhrle C. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc. Natl Acad. Sci. USA 2002; 99: 16267-16272.
21. Bulte JW, Douglas T, Witwer B, Zhang SC, Strable E, Lewis BK, Zywicke H, Miller B, van Gelderen P, Moskowitz BM, Duncan ID, Frank JA. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat. Biotechnol. 2001; 19: 1141-1147.
22. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003; 24: 1001-1011.
23. Berry CC, Wells S, Charles S, Aitchison G, Curtis AS. Cell response to dextran-derivatised iron oxide nanoparticles post internalization. Biomaterials 2004; 25: 5405-5413.
24. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Bulte JW, Frank JA. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation 2003; 76: 1123-1130.
25. Stroh A, Zimmer C, Gutzeit C, Jackstadt M, Marschinke F, Jung T, Pilgrimm H, Grune T. Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free Radic. Biol. Med. 2004; 36: 976-984.
26. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004; 17: 513-517.
27. Sun R, Dittrich J, Le-Huu M, Mueller MM, Bedke J, Kartenbeck J, Lehmann WD, Krueger R, Bock M, Huss R, Seliger C, Grone HJ, Misselwitz B, Semmler W, Kiessling F. Physical and biological characterization of superparamagnetic iron oxide- and ultrasmall superparamagnetic iron oxide-labeled cells: a comparison. Invest Radiol. 2005; 40: 504-513.
28. 1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions. Magn. Reson. Med. 1992; 23: 275-286.
29. Thelwall PE, Grant SC, Stanisz GJ, Blackband SJ. Human erythrocyte ghosts: exploring the origins of multiexponential water diffusion in a model biological tissue with magnetic resonance. Magn. Reson. Med. 2002; 48: 649-657.
30. Bacic G, Alameda JC Jr, Iannone A, Magin RL, Swartz HM. NMR study of water exchange across the hepatocyte membrane. Magn. Reson. Imag. 1989; 7: 411-416.
31. Minard KR, Holtom GR, Kathmann LE, Majors PD, Thrall BD, Wind RA. Simultaneous 1H PFG-NMR and confocal microscopy of monolayer cell cultures: effects of apoptosis and necrosis on water diffusion and compartmentalization. Magn. Reson. Med. 2004; 52: 495-505.
32. Tanimoto A, Oshio K, Suematsu M, Pouliquen D, Stark DD. Relaxation effects of clustered particles. J. Magn. Reson. Imag. 2001; 14: 72-77.
33. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest. Radiol. 2005; 40: 715-724.
34. Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, Fobker M, Poremba C, Ebert W, Heindel W, Bremer C. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 2005; 235: 155-161.
35. Mailänder V, Lorenz MR, Holzapfel V, Musyanovych A, Fuchs K, Wiesneth M, Walther P, Landfester K, Schrezenmeier H. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol. Imag. Biol. 2008; 10: 138-146.
36. Neuberger T, Schöpf B, Hofmann H, Hofmann M, von Rechenberg B. Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 2005; 293: 483-496.
37. Elfick AP, Green SM, McCaskie AW, Birch MA. Opsonization of polyethylene wear particles regulates macrophage and osteoblast responses in vitro. J. Biomed. Mater. Res. Appl. Biomater. 2004; 71: 244-251.
38. Tabata Y, Ikada Y. Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 1988; 9: 356-362.
39. Berry CC, Wells S, Charles S, Curtis AS. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003; 24: 4551-4557.
40. Lind K, Kresse M, Muller RH. Comparison of protein adsorption patterns onto differently charged hydrophilic superparamagnetic iron oxide particles obtained in vitro and ex vivo. Electrophoresis 2001; 22: 3514-3521.
41. Thode K, Luck M, Semmler W, Muller RH, Kresse M. Determination of plasma protein adsorption on magnetic iron oxides: sample preparation. Pharm. Res. 1997; 14: 905-910.
42. Montet-Abou K, Montet X, Weissleder R, Josephson L. Transfection agent induced nanoparticle cell loading. Mol. Imag. 2005; 4: 165-171.
43. Kalish H, Arbab AS, Miller BR, Lewis BK, Zywicke HA, Bulte JW, Brant LH Jr, Frank JA. Combination of transfection agents and magnetic resonance contrast agents for cellular imaging: relationship between relaxivities, electrostatic forces, and chemical composition. Magn. Reson. Med. 2003; 50: 275-282.
44. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur. Radiol. 2004; 14: 1851-1858.
45. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175: 489-493.
46. Fleige G, Seeberger F, Laux D, Kresse M, Taupitz M, Pilgrimm H, Zimmer C. In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking. Invest. Radiol. 2002; 37: 482-488.